Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-09-26 4:04 pm Purchase | 2022-09-20 | 13D | Milestone Pharmaceuticals Inc. MIST | Novo Holdings A/S | 2,097,713 7.000% | 16,828 (+0.81%) | Filing History |
| 2022-09-16 2:27 pm Purchase | 2022-09-14 | 13D | Edgewise Therapeutics, Inc. EWTX | Novo Holdings A/S | 6,071,703 9.600% | 484,496 (+8.67%) | Filing History |
| 2022-08-18 1:30 pm Sale | 2022-08-12 | 13D | Mirum Pharmaceuticals, Inc. MIRM | Novo Holdings A/S | 1,760,000 4.800% | -129,127 (-6.84%) | Filing History |
| 2022-08-02 3:31 pm Sale | 2022-08-01 | 13D | Mirum Pharmaceuticals, Inc. MIRM | Novo Holdings A/S | 1,889,127 5.900% | -310,873 (-14.13%) | Filing History |
| 2022-07-22 6:37 pm Sale | 2022-07-20 | 13D | CYTEIR THERAPEUTICS INC CYTT | Novo Holdings A/S | 3,940,413 11.100% | -900,000 (-18.59%) | Filing History |
| 2022-07-15 4:01 pm Sale | 2022-07-13 | 13D | Bolt Biotherapeutics, Inc. BOLT | Novo Holdings A/S | 185,200 9.800% | -40,000 (-17.76%) | Filing History |
| 2022-06-03 3:01 pm Sale | 2022-05-31 | 13D | Checkmate Pharmaceuticals, Inc. CMPI | Novo Holdings A/S | 0 0.000% | -1,828,484 (Position Closed) | Filing History |
| 2022-06-03 1:35 pm Unchanged | 2022-05-12 | 13D | Nkarta, Inc. NKTX | Novo Holdings A/S | 2,238,309 4.600% | 0 (Unchanged) | Filing History |
| 2022-05-26 11:57 am Unchanged | 2022-05-25 | 13D | IO Biotech, Inc. IOBT | Novo Holdings A/S | 3,277,932 11.300% | 0 (Unchanged) | Filing History |
| 2022-05-11 2:57 pm Sale | 2022-05-05 | 13D | Checkmate Pharmaceuticals, Inc. CMPI | Novo Holdings A/S | 1,828,484 8.300% | -341,616 (-15.74%) | Filing History |
| 2022-05-02 1:52 pm Sale | 2022-04-26 | 13D | Nkarta, Inc. NKTX | Novo Holdings A/S | 2,238,309 6.700% | -555,556 (-19.88%) | Filing History |
| 2022-04-08 2:49 pm Sale | 2022-03-31 | 13D | Mirum Pharmaceuticals, Inc. MIRM | Novo Holdings A/S | 2,200,000 6.900% | -245,147 (-10.03%) | Filing History |
| 2022-02-22 2:11 pm Sale | 2022-02-17 | 13D | Morphic Holding, Inc. MORF | Novo Holdings A/S | 1,845,030 4.900% | -205,416 (-10.02%) | Filing History |
| 2022-02-09 5:18 pm Purchase | 2022-02-03 | 13G | Arcellx, Inc. ACLX | Novo Holdings A/S | 4,016,878 11.400% | 4,016,878 (New Position) | Filing History |
| 2022-02-02 5:00 pm Purchase | 2021-12-31 | 13G | Exscientia plc EXAI | Novo Holdings A/S | 13,086,600 11.000% | 13,086,600 (New Position) | Filing History |
| 2022-02-02 4:57 pm Purchase | 2021-12-31 | 13G | Evotec SE EVO | Novo Holdings A/S | 17,894,807 10.200% | 17,894,807 (New Position) | Filing History |
| 2022-02-02 4:55 pm Sale | 2021-12-31 | 13G | Galera Therapeutics, Inc. GRTX | Novo Holdings A/S | 2,459,021 9.300% | -500,000 (-16.90%) | Filing History |
| 2022-01-31 4:28 pm Sale | 2022-01-28 | 13D | Aligos Therapeutics, Inc. ALGS | Novo Holdings A/S | 78,000 4.900% | -26,583 (-25.42%) | Filing History |
| 2022-01-27 3:31 pm Unchanged | 2022-01-20 | 13D | Reneo Pharmaceuticals, Inc. RPHM | Novo Holdings A/S | 343,038 14.000% | 0 (Unchanged) | Filing History |
| 2021-12-20 1:00 pm Unchanged | 2021-12-15 | 13D | CYTEIR THERAPEUTICS INC CYTT | Novo Holdings A/S | 4,840,413 13.600% | 0 (Unchanged) | Filing History |